Pfizer shares owned by Kathmere Capital Management
Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Kathmere Capital Management
from 13F filings
Historical chart of Kathmere Capital Management investment in Pfizer
Tip: Access up to 7 years of quarterly data
All positions including Pfizer held by Kathmere Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pfizer by Kathmere Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $832k | 33k | 25.48 |
| 2025-06-30 | $637k | 26k | 24.24 |
| 2025-03-31 | $242k | 9.6k | 25.34 |
| 2024-03-31 | $203k | 7.3k | 27.75 |
| 2023-09-30 | $380k | 12k | 33.17 |
| 2023-06-30 | $267k | 7.3k | 36.68 |
| 2022-12-31 | $236k | 5.2k | 44.98 |
| 2022-09-30 | $253k | 5.8k | 43.71 |
| 2022-06-30 | $273k | 5.2k | 52.46 |
| 2022-03-31 | $247k | 4.8k | 51.84 |
| 2020-12-31 | $61k | 1.7k | 36.90 |
| 2020-09-30 | $24k | 653 | 36.75 |
More positions owned by Kathmere Capital Management
View all positions for Kathmere Capital Management